Cimzia: payments to doctors
Payments that named Cimzia as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $10.7M
- Providers
- 23,209
- Transactions
- 214,711
- Average per transaction
- $50
The per-transaction average — $50 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 23,209 providers the average total is $460, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| UCB, Inc. | $10,271,458 | 96.1% |
| Ferring Pharmaceuticals Inc. | $224,985 | 2.1% |
| UCB SA | $174,240 | 1.6% |
| UCB GmbH | $7,075 | 0.1% |
| UCB Biosciences Inc. | $5,605 | 0.1% |